Steering Committee

Brooke Kempf

PMHNP-BC
Adjunct Faculty
Indiana University Indianapolis

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

2026 Sessions

MasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond

Many patients with MDD experience only partial improvement despite adequate antidepressant therapy. This session focuses on recognizing clinically meaningful residual symptoms, reviews emerging evidence for adjunctive pharmacologic options, and provides practical approaches to optimizing treatment with the goal of achieving remission and sustained recovery.<br><br>Supported by an educational grant from Johnson & Johnson.

Speaker

Wednesday, September 16 2:45–4:15 PM
Room Great Hall D
Faculty

Christoph Correll

MD
Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1000 journal articles that have been cited more than 94.000 times, and in 05/2025, his h-index was 153, being >100 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 05/2025 being ranked number one among world experts in 9 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Steering Committee

Brooke Kempf

PMHNP-BC
Adjunct Faculty
Indiana University Indianapolis

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

When Standard Treatment Isn’t Enough: Complex Schizophrenia Cases and Clinical Decision-Making

Not all patients with schizophrenia respond predictably to first-line antipsychotic therapy. This panel discussion uses challenging clinical cases to examine treatment resistance, persistent positive symptoms, comorbid mood instability, and functional decline. Faculty will discuss sequencing strategies, clozapine timing, augmentation options, and managing adverse effects such as metabolic burden and sedation. Attendees will gain step-by-step guidance on refining treatment plans when conventional approaches fail to produce meaningful recovery.

Speaker

Saturday, September 19 1:30–2:30 PM
Room Great Hall A
Schizophrenia
Consultant

Leslie Citrome

MD, MPH
Clinical Professor, Psychiatry and Behavioral Sciences
New York Medical College

Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York, and Adjunct Professor at the Northwestern Feinberg School of Medicine in Chicago, Illinois. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after about two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is currently engaged as a consultant in clinical trial design and interpretation, and has remained clinically active providing assistance to patients and their families through the Assertive Community Treatment program operated by the Mental Health Association of Rockland County through 2025. Dr. Citrome is a former President of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder, as well as tardive dyskinesia. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author/ co-author of over 600 research reports, reviews, and book chapters in the scientific literature, is Editor-in-Chief of Current Medical Research and Opinion published by Taylor & Francis, Editor Emeritus at the International Journal of Clinical Practice and where he served as Editor-in-Chief from 2013 through 2019, reviews for over 75 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

Consultant

Erin Crown

MHS, PA-C, CAQ-Psychiatry
Managing Member
Oasis LifeCare

Erin Crown is a Board Certified Physician Assistant with a Certificate of Added Qualifications in Psychiatry, and the Managing Member of Oasis LifeCare in State College, PA. Having formerly provided care on an inpatient stabilization unit, she currentlly practices psychiatry in the outpatient setting and leads a first episode psychosis program.. She is the owner of Future Options Research and is the Principal Investigator for multiple clinical trials. Erin is the past Chair of the NCCPA Health Foundation, a member of the PArtners in Mental Health Steering Committee, and is also working with AAPA and the PA Foundation to bring trauma informed education to school districts across the country.

Steering Committee

Brooke Kempf

PMHNP-BC
Adjunct Faculty
Indiana University Indianapolis

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Back to top